Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
ASPIRE
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
1 other identifier
interventional
1,081
26 countries
204
Brief Summary
To evaluate the overall effectiveness of aripiprazole intramuscular (IM) depot as maintenance treatment in patients with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 schizophrenia
Started Dec 2008
Longer than P75 for phase_3 schizophrenia
204 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2008
CompletedFirst Posted
Study publicly available on registry
August 11, 2008
CompletedStudy Start
First participant enrolled
December 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedResults Posted
Study results publicly available
November 11, 2014
CompletedNovember 26, 2014
November 1, 2014
4.9 years
August 5, 2008
November 4, 2014
November 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Stable Participants at Baseline Who Remained Stable at Endpoint (Last Visit).
"Stable" was defined as meeting all of the following criteria: Outpatient status; Positive and negative syndrome scale (PANSS) total score ≤ 80; Lack of specific psychotic symptoms on the PANSS as measured by a score of ≤ 4 on each of the following items (possible scores of 1 to 7 for each item): 1) conceptual disorganization 2) suspiciousness 3) hallucinatory behavior 4) unusual thought content; Clinical Global Impression of Severity (CGI-S) ≤ 4 (moderately ill); and Clinical Global Impression for Severity of Suicidality (CGI-SS) ≤ 2 (mildly suicidal) on Part 1 and ≤ 5 (minimally worsened) on Part 2. The percentage of stable participants at baseline who remain stable at endpoint (last visit) is described here.
Baseline to Week 52/Last visit
Secondary Outcomes (9)
Percentage of Participants Meeting Exacerbation of Psychotic Symptoms/Impending Relapse Criteria.
Weeks 2,4,8,12,16,20,24,28,32,36,40,44,48,52, and Last visit (upto 4 weeks ± 3 days after completion or withdrawal)
Percentage of Participants Achieving Remission.
Overall remission from Weeks 2,4,8,12,16,20,24,28,32,36,40,44,48 and 52
Percentage of Participants Stable at Baseline and Remaining Stable at Week 28.
Baseline to Week 28
Percentage of Participants With Time to First Exacerbation of Psychotic Symptoms/Impending Relapse.
Baseline to Week 52
Mean Change From Baseline to Endpoint (Last Visit) in Positive and Negative Syndrome Scale (PANSS) Total Score.
Baseline, Weeks 12, 24, 52 and last visit
- +4 more secondary outcomes
Study Arms (1)
1
EXPERIMENTALActive Treatment of aripiprazole IM depot (300mg or 400mg)
Interventions
Eligibility Criteria
You may qualify if:
- Subjects who are able to provide written informed consent and/or consent obtained from a legally acceptable representative (as require by IRB/IEC), prior to the initiation of any protocol-required procedures.
- Male and female subjects 18 to 65 years of age, inclusive, at time of informed consent.
- Subjects who complete Studies 246/247 or who withdrew from the double-blind maintenance phase of either study (Phase 4 of Study 246 or Phase 3 of Study 247), or new subjects not participating in Studies 246/247.
- \# Subjects who, in the investigator's judgment, require chronic treatment with an antipsychotic medication.
- Subjects able to understand the nature of the study and follow protocol requirements, including the prescribed dosage regimens, tablet ingestion, IM depot injection, discontinuation of prohibited concomitant medications, who can read and understand the written word in order to complete patient-reported outcomes measures, and who can be reliably rated on assessment scales.
You may not qualify if:
- Subjects with a current DSM-IV-TR diagnosis other than schizophrenia, including schizoaffective disorder, major depressive disorder, bipolar disorder, delirium, dementia, amnestic or other cognitive disorders. Also, subjects with borderline, paranoid, histrionic, schizotypal, schizoid or antisocial personality disorder.
- Subjects with schizophrenia that are considered resistant/refractory to antipsychotic treatment by history or response only to clozapine.
- Subjects with a significant risk of violent behavior or a significant risk of committing suicide based on history or investigator's judgment.
- Subjects who currently meet DSM-IV-TR criteria for substance dependence; including alcohol and benzodiazepines, but excluding caffeine and nicotine, or two positive drug screens for cocaine.
- Subjects who are known to be allergic, intolerant, or unresponsive to prior treatment with aripiprazole or other quinolinones.
- Subjects with a history of hypersensitivity to antipsychotic agents.
- Subjects with a history of neuroleptic malignant syndrome or clinically significant tardive dyskinesia at screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (214)
Unknown Facility
Chandler, Arizona, 85226, United States
Unknown Facility
Anaheim, California, 92804, United States
Unknown Facility
Cerritos, California, 90703, United States
Unknown Facility
Chino, California, 91710, United States
Unknown Facility
Escondido, California, 92025, United States
Unknown Facility
Garden Grove, California, 92845, United States
Unknown Facility
Glendale, California, 91204, United States
Unknown Facility
Glendale, California, 91206, United States
Unknown Facility
Imperial, California, 92251, United States
Unknown Facility
La Habra, California, 90631, United States
Unknown Facility
Los Angeles, California, 90024, United States
Unknown Facility
National City, California, 91950, United States
Unknown Facility
Oceanside, California, 92056, United States
Unknown Facility
Orange, California, 92868, United States
Unknown Facility
Pasadena, California, 91106, United States
Unknown Facility
Pico Rivera, California, 90660, United States
Unknown Facility
San Bernardino, California, 92408, United States
Unknown Facility
San Diego, California, 92102, United States
Unknown Facility
San Diego, California, 92103, United States
Study Site
San Diego, California, 92123, United States
Unknown Facility
San Diego, California, 92123, United States
Unknown Facility
Sherman Oaks, California, 91403, United States
Unknown Facility
Torrance, California, 90502, United States
Unknown Facility
Highlands Ranch, Colorado, 80130, United States
Unknown Facility
Norwalk, Connecticut, 06851, United States
Unknown Facility
Washington D.C., District of Columbia, 20016, United States
Unknown Facility
Bradenton, Florida, 34208, United States
Unknown Facility
Coral Springs, Florida, 33065, United States
Unknown Facility
Doral, Florida, 33166, United States
Unknown Facility
Gainesville, Florida, 32606, United States
Unknown Facility
Hollywood, Florida, 33021, United States
Unknown Facility
Kissimmee, Florida, 34741, United States
Unknown Facility
Maitland, Florida, 32751, United States
Unknown Facility
Miami, Florida, 33135, United States
Unknown Facility
Orange City, Florida, 32763, United States
Unknown Facility
Orlando, Florida, 32839, United States
Unknown Facility
Plantation, Florida, 33317, United States
Unknown Facility
Tampa, Florida, 33613, United States
Unknown Facility
Atlanta, Georgia, 30328, United States
Unknown Facility
Chicago, Illinois, 60612, United States
Unknown Facility
Chicago, Illinois, 60640, United States
Unknown Facility
Hoffman Estates, Illinois, 60169, United States
Unknown Facility
Oak Brook, Illinois, 60523, United States
Unknown Facility
Indianapolis, Indiana, 46222, United States
Unknown Facility
Baton Rouge, Louisiana, 70808, United States
Unknown Facility
Baton Rouge, Louisiana, 70809, United States
Unknown Facility
Lake Charles, Louisiana, 70629, United States
Unknown Facility
New Orleans, Louisiana, 70115, United States
Unknown Facility
Shreveport, Louisiana, 71101, United States
Unknown Facility
Columbia, Maryland, 21045, United States
Unknown Facility
Flowood, Mississippi, 39232, United States
Unknown Facility
Kansas City, Missouri, 64108, United States
Unknown Facility
St Louis, Missouri, 63109, United States
Unknown Facility
St Louis, Missouri, 63118, United States
Unknown Facility
North Platte, Nebraska, 69101, United States
Unknown Facility
Albuquerque, New Mexico, 87131, United States
Unknown Facility
Buffalo, New York, 14213, United States
Unknown Facility
Buffalo, New York, 14215, United States
Unknown Facility
Cedarhurst, New York, 11516, United States
Unknown Facility
Holliswood, New York, 11423, United States
Unknown Facility
Jamaica, New York, 11418, United States
Unknown Facility
New York, New York, 10003, United States
Unknown Facility
New York, New York, 10027, United States
Unknown Facility
Rochester, New York, 14615, United States
Unknown Facility
Hickory, North Carolina, 28601, United States
Unknown Facility
Winston-Salem, North Carolina, 27104, United States
Unknown Facility
Canton, Ohio, 44718, United States
Unknown Facility
Cincinnati, Ohio, 45219, United States
Unknown Facility
Cleveland, Ohio, 44109, United States
Unknown Facility
Garfield Heights, Ohio, 44125, United States
Unknown Facility
Middleburg Heights, Ohio, 44130, United States
Unknown Facility
Toledo, Ohio, 43609, United States
Unknown Facility
Oklahoma City, Oklahoma, 73103, United States
Unknown Facility
Oklahoma City, Oklahoma, 73112, United States
Unknown Facility
Oklahoma City, Oklahoma, 73139, United States
Unknown Facility
Allentown, Pennsylvania, 18104, United States
Unknown Facility
Jenkintown, Pennsylvania, 19046, United States
Unknown Facility
Media, Pennsylvania, 19063, United States
Unknown Facility
Philadelphia, Pennsylvania, 19131, United States
Unknown Facility
Philadelphia, Pennsylvania, 19139, United States
Unknown Facility
Pittsburgh, Pennsylvania, 15213, United States
Unknown Facility
Sellersville, Pennsylvania, 18960, United States
Unknown Facility
Charleston, South Carolina, 29401, United States
Unknown Facility
Charleston, South Carolina, 29407, United States
Unknown Facility
Charleston, South Carolina, 29425, United States
Unknown Facility
Johnson City, Tennessee, 37614-1707, United States
Unknown Facility
Memphis, Tennessee, 38119, United States
Unknown Facility
Nashville, Tennessee, 37212, United States
Unknown Facility
Austin, Texas, 78731, United States
Unknown Facility
Austin, Texas, 78754, United States
Unknown Facility
DeSoto, Texas, 75115, United States
Unknown Facility
Richmond, Virginia, 23230, United States
Unknown Facility
Bellevue, Washington, 98007, United States
Unknown Facility
Bothell, Washington, 98011, United States
Unknown Facility
Spokane, Washington, 99204, United States
Unknown Facility
Milwaukee, Wisconsin, 53226, United States
Unknown Facility
Buenos Aires, C1058AAJ, Argentina
Unknown Facility
Buenos Aires, C1405BOA, Argentina
Unknown Facility
Buenos Aires, C1425AHQ, Argentina
Unknown Facility
Cordoba, Cordoba, X5009BIN, Argentina
Unknown Facility
La Plata, Buenos Aires, Argentina
Unknown Facility
Mendoza, 5500HYF, Argentina
Unknown Facility
Dandenong, Victoria, 3175, Australia
Unknown Facility
Epping, Victoria, 3076, Australia
Unknown Facility
Frankston, Victoria, 3199, Australia
Unknown Facility
Fremantle, Western Australia, 6959, Australia
Unknown Facility
Glenside, SA, 5063, Australia
Unknown Facility
Melbourne, VIC 3004, Australia
Unknown Facility
Innsbruck, A-6020, Austria
Unknown Facility
Bruges, 8200, Belgium
Unknown Facility
Burgas, 8000, Bulgaria
Unknown Facility
Lovech, 5500, Bulgaria
Unknown Facility
Pazardzhik, 4400, Bulgaria
Unknown Facility
Pleven, 5800, Bulgaria
Unknown Facility
Plovdiv, 4002, Bulgaria
Unknown Facility
Radnevo, 6260, Bulgaria
Unknown Facility
Rousse, 7003, Bulgaria
Unknown Facility
Sofia, 1113, Bulgaria
Unknown Facility
Sofia, 1431, Bulgaria
Unknown Facility
Sofia, 1632, Bulgaria
Unknown Facility
Varna, 9001, Bulgaria
Unknown Facility
Veliko Tarnovo, 5007, Bulgaria
Unknown Facility
San Bernardo, Santiago, 8780000, Chile
Unknown Facility
Santiago, 7500710, Chile
Unknown Facility
Santiago, 7510186, Chile
Unknown Facility
Santiago, 7580307, Chile
Unknown Facility
Santiago, 8330838, Chile
Unknown Facility
Santiago, 8900085, Chile
Unknown Facility
Santiago, Chile
Unknown Facility
Zagreb, 10 090, Croatia
Unknown Facility
Zagreb, 10000, Croatia
Unknown Facility
Jämejala, 71024, Estonia
Unknown Facility
Tallinn, 10614, Estonia
Unknown Facility
Tallinn, 10617, Estonia
Unknown Facility
Tartu, 50406, Estonia
Unknown Facility
Helsinki, 00250, Finland
Unknown Facility
Élancourt, 78990, France
Unknown Facility
Rennes, 35703, France
Unknown Facility
Saint-Nazaire, 44606, France
Unknown Facility
Baja, 6500, Hungary
Unknown Facility
Balassagyarmat, 2660, Hungary
Unknown Facility
Cegléd, 2700, Hungary
Unknown Facility
Győr, 9023, Hungary
Unknown Facility
Ahmedabad, Gujarat, 380006, India
Unknown Facility
Bangalore, Karnataka, 560010, India
Unknown Facility
Chennai, Tamil Nadu, 600003, India
Unknown Facility
Kanpur, 208005, India
Unknown Facility
Mangalore, 575018, India
Unknown Facility
Pune, 411004, India
Unknown Facility
Tirupati, 517507, India
Unknown Facility
Kuala Lumpur, Kuala Lumpur, 50603, Malaysia
Unknown Facility
Kuala Lumpur, Kuala Lumpur, 56000, Malaysia
Unknown Facility
Tanjong Rambutan, Perak, 31250, Malaysia
Unknown Facility
Kuala Selangor, 43000, Malaysia
Unknown Facility
Guadalajara, Jalisco, 44280, Mexico
Unknown Facility
Mexico City, Mexico City, 6700, Mexico
Unknown Facility
Monterrey, Nuevo León, 64040, Mexico
Unknown Facility
San Luis Potosí City, San Luis Potosí, 78218, Mexico
Unknown Facility
Culiacán, Sinaloa, 80020, Mexico
Unknown Facility
Ålesund, 6018, Norway
Unknown Facility
Klepp stasjon, 4353, Norway
Unknown Facility
Bataan, Central Luzon, 2105, Philippines
Unknown Facility
Mandaluyong, NCR, 1553, Philippines
Unknown Facility
Quezon City, NCR, 1104, Philippines
Unknown Facility
Iloilo City, Western Visayas, 5000, Philippines
Unknown Facility
Bełchatów, 97-400, Poland
Unknown Facility
Bialystok, 15-879, Poland
Unknown Facility
Bydgoszcz, 85096, Poland
Unknown Facility
Choroszcz, 16-070, Poland
Unknown Facility
Krakow, 31-501, Poland
Unknown Facility
Leszno, 64-100, Poland
Unknown Facility
Pruszków, 05-802, Poland
Unknown Facility
Sosnowiec, 41-200, Poland
Unknown Facility
Wroclaw, 50-227, Poland
Unknown Facility
San Juan, 00918, Puerto Rico
Unknown Facility
Arad, 310022, Romania
Unknown Facility
Bucharest, 041914, Romania
Unknown Facility
Cluj-Napoca, 400012, Romania
Unknown Facility
Craiova, 200620, Romania
Unknown Facility
Oradea, 410154, Romania
Unknown Facility
Piteşti, 110069, Romania
Unknown Facility
Lipetsk, 398007, Russia
Unknown Facility
Moscow, 115522, Russia
Unknown Facility
Moscow, 127083, Russia
Unknown Facility
Nizhny Novgorod, 603152, Russia
Unknown Facility
Nizhny Novgorod, 603155, Russia
Unknown Facility
Saint Petersburg, 188357, Russia
Unknown Facility
Saint Petersburg, 190121, Russia
Unknown Facility
Saint Petersburg, 192019, Russia
Unknown Facility
Smolensk, 214019, Russia
Unknown Facility
Belgrade, 11000, Serbia
Unknown Facility
Kragujevac, 34000, Serbia
Unknown Facility
Košice, 041 90, Slovakia
Unknown Facility
Liptovský Mikuláš, 3101, Slovakia
Unknown Facility
Prešov, 8001, Slovakia
Unknown Facility
Rimavská Sobota, 97901, Slovakia
Unknown Facility
Svidník, 089 01, Slovakia
Unknown Facility
Pretoria, Gauteng, 0001, South Africa
Unknown Facility
Cape Town, Western Province, 7530, South Africa
Unknown Facility
Busan, 614-735, South Korea
Unknown Facility
Deajeon, 301-721, South Korea
Unknown Facility
Gwangju, 501-757, South Korea
Unknown Facility
Joong-gu, Incheon, 400-700, South Korea
Unknown Facility
Seoul, 110-744, South Korea
Unknown Facility
Seoul, 137-701, South Korea
Unknown Facility
Seoul, 150-950, South Korea
Unknown Facility
Barcelona, 08036, Spain
Unknown Facility
Barcelona, 08907, Spain
Unknown Facility
Barcelona, 8005, Spain
Unknown Facility
Tainan, 704, Taiwan
Unknown Facility
Taipei, 11086, Taiwan
Unknown Facility
Muang, Chiangmai, 50100, Thailand
Unknown Facility
Muang, Chiangmai, 50200, Thailand
Unknown Facility
Bangkok, 10330, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Global Medical Affairs
- Organization
- Otsuka Pharmaceutical Development & Commercialization, Inc
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2008
First Posted
August 11, 2008
Study Start
December 1, 2008
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 26, 2014
Results First Posted
November 11, 2014
Record last verified: 2014-11